News
Hosted on MSN11m
2 Beaten-Down Dividend Growth Stocks to Buy on the DipShares of Novo Nordisk peaked last year as enthusiasm for anti ... Wegovy for obesity. The company reported first-quarter sales of semaglutide that rose by 50.3% year over year. Sales of tirzepatide, ...
Pharmaceutical giant Eli Lilly delivers strong financial results and has a deep lineup and pipeline. Much smaller Viking Therapeutics boasts several candidates whose progress could jolt its shares.
Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...
Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...
India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expirations of blockbuster drugs. Pharmaceutical giants are ...
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results